Date & Time
April 04 – 05, 2025
The scientific programm is scheduled to start on Friday at 13:00 and end on Saturday at 14:30.
Venue
Sheraton Novi Sad
Polgar Andraša 1
Novi Sad, Serbia 21000
Contact
Please contact us at cecog@wma.co.at for any questions related to the meeting.
Programme
In 2018 CECOG started an annual event on thoracic cancers – the CECOG Thoracic Cancers Academy. This event has now already become an annual tradition and was held in a rotating way in various major cities of the geographic region of Central and South-eastern Europe.
The CECOG Thoracic Academy is intended for all researchers and specialists being involved in research and/or treatment of thoracic malignancies: molecular biologists, pathologists, radiologists, surgeons, medical oncologists, radiation oncologists, pulmonologists, and palliative care specialists.
The Scientific Committee of the CECOG Thoracic Cancers Academy is the following:
Christoph Zielinski (Vienna, Austria)
Christiane Thallinger (Vienna, Austria)
Tanja Čufer (Ljubljana, Slovenia)
Bojan Zaric (Novi Sad, Serbia)
Friday, 4 April 2025
| Start | End | Session / Presentations |
|---|---|---|
| 13:00 | 13:15 | Welcome Session |
| Chair | B. Zaric, Novi Sad | |
| Chair | C. Zielinski, Vienna | |
| Welcome | ||
| Speaker | B. Zaric, Novi Sad | |
| Introduction to CECOG | ||
| Speaker | C. Zielinski, Vienna | |
| 13:15 | 14:05 | News in screening and staging |
| Chair | M. Jakopovic, Zagreb | |
| Chair | J. Djekic, Novi Sad | |
| 13:15 | 13:40 | Lung cancer screening - where are we exactly? |
| Speaker | T. Blum, Göttingen, Germany | |
| 13:40 | 14:05 | Overview of TNM 9 - lung cancer, pleural mesothelioma and thymic malignancies |
| Speaker | E. Talakic, Graz | |
| 14:05 | 14:35 | Industry Session by Amicus/BMS |
| 14:35 | 14:50 | Coffee Break |
| 14:50 | 16:05 | Resectable NSCLC - rapidly changing treatment paradigms |
| Chair | MA. Hoda, Vienna | |
| Chair | J. But Hadzic, Ljubljana | |
| 14:50 | 15:15 | Surgery for resectable NSCLC - when and what? |
| Speaker | MA. Hoda, Vienna | |
| 15:15 | 15:40 | SBRT for operable and inoperable NSCLC |
| Speaker | J. But Hadzic, Ljubljana | |
| 15:40 | 16:05 | Perioperative systemic treatment for resectable NSCLC |
| Speaker | T. Cufer, Ljubljana | |
| 16:05 | 17:05 | Industry Session by Astra Zeneca |
| 17:05 | 17:20 | Coffee Break |
| 17:20 | 18:10 | Locally advanced and advanced NSCLC |
| Chair | T. Cufer, Ljubljana | |
| Chair | B. Zaric, Novi Sad | |
| 17:20 | 17:45 | Histology and molecular pathology of NSCLC |
| Speaker | I. Kern, Golnik | |
| 17:45 | 18:10 | Treatment of non-oncogene-addicted advanced NSCLC |
| Speaker | B. Zaric, Novi Sad | |
| 18:10 | 18:25 | Coffee Break |
| 18:25 | 19:15 | Palliative and supportive care in metastatic lung cancer |
| Chair | S. Plestina, Zagreb | |
| Chair | I. Kuhjada, Novi Sad | |
| 18:25 | 18:50 | Interventional bronchoscopy options for palliative patients |
| Speaker | A. Rozman, Golnik | |
| 18:50 | 19:15 | Optimal supportive therapy in lung cancer patients |
| Speaker | T. Kovacevic, Novi Sad | |
| 19:15 | 20:15 | Welcome Reception |
Saturday, 5 April 2025
| Start | End | Session / Presentation |
|---|---|---|
| 09:00 | 10:15 | Pleural Mesothelioma - whats new? |
| Chair | MA. Hoda, Vienna | |
| Chair | M. Jakopovic, Zagreb | |
| 09:00 | 09:25 | Update on histology and molecular pathology in PM |
| Speaker | Luka Brcic, Graz | |
| 09:25 | 09:50 | The current role of radiation in PM |
| Speaker | T. Boskovic, Novi Sad | |
| 09:50 | 10:15 | Systemic options including IO in PM |
| Speaker | M. Jakopovic, Zagreb | |
| 10:15 | 11:15 | Industry Session by Pfizer |
| 11:15 | 11:30 | Coffee Break |
| 11:30 | 12:10 | Young oncologists MDT Session (bring your case to discuss with the experts) |
| Chair | B. Zaric, M. Jakopovic, J. But Hadzic, T. Cufer, L. Brcic | |
| 11:30 | 11:50 | Case presentation (10 min presentation + 5 min expert comment + 5 min discussion) |
| TBA | ||
| 11:50 | 12:10 | Case presentation (10 min presentation + 5 min expert comment + 5 min discussion) |
| TBA | ||
| 12:10 | 12:25 | Coffee Break |
| 12:25 | 12:55 | Industry Session by MSD |
| 12:55 | 14:10 | SCLC and Thymic Malignancies |
| Chair | T. Cufer, Ljubljana | |
| Chair | D. Radosavljevic, Belgrade | |
| 12:55 | 13:20 | Biomarkers in SCLC - is there any progress |
| Speaker | J Moldvay, Budapest | |
| 13:20 | 13:45 | Systemic treatment of SCLC (including novel approaches) |
| Speaker | J. Spasic, Belgrade | |
| 13:45 | 14:10 | Thymic Malignancies: Current standards in treatment |
| Speaker | S. Plestina, Zagreb | |
| 14:10 | 14:40 | Keynote Lecture |
| Tracing Cancer Diagnosis and Treatment - an Overview over 1.7 Million Years | ||
| Speaker | C. Zielinski, Vienna | |
| 14:40 | 14:50 | Closing and Farewell |
| Speaker | T. Cufer, Ljubljana | |
| Speaker | B Zaric, Novi Sad |
Please Note: This is a preliminary program, and the schedule or content may be subject to change. We will keep you informed of any updates as they occur. Thank you for your understanding
Registration & Accommodation Booking
The number of participants is limited to a maximum of 100 attendees.
No registration fees are charged for this meeting. One night accommodation at the meeting hotel will be covered by CECOG.
Registration is facilitated through an application process with the CECOG team. Our aim is to curate a diverse conference that encompasses a range of perspectives by including different specialities, geographic regions and levels of experience.
Once the application process is concluded, accepted participants will be able to book their accommodation through the CECOG website. Please note that all travel arrangements are the responsibility of the participants. We strongly advise waiting for a confirmation from CECOG before making any travel plans.
Financial Support
Do you want to be part of this exciting event? Make use of our various sponsoring options!
Contact us for more information at cecog@wma.co.at.